More consistent medication access When cost barriers fall, patients are more likely to stay on treatment long enough to experience meaningful results
see NHS guidance on unintentional weight loss You are pregnant, breastfeeding, under 18, or have a BMI below 18.5 calorie restriction in these groups requires specific clinical guidance and should not be undertaken without professional support You are concerned about your relationship with food or eating if you think you may be at risk of an eating disorder, speak to your GP or contact Beat (beateatingdisorders.org.uk) Your GP can arrange relevant investigations, including thyroid function tests, HbA1c (the standard first-line test for glycaemia in primary care), and a full blood count
PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) maps 14 metabolic pathways and analyzes 49 peptides across 150+ genetic insights, including these rebound-risk variants
Understanding whether this symptom stems directly from semaglutide's mechanism, indirect factors like reduced fluid intake, or concurrent medications helps patients and clinicians address concerns appropriately and maintain treatment adherence
The result is a flat, firm, and rejuvenated midsection
This peptide combination enhances lean muscle mass, aids in fat loss, and promotes overall rejuvenation by stimulating growth hormone production
